Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

Patients with myeloid neoplasms who relapsed after allogenic hematopoietic stem cell transplant (HSCT) have poor prognosis. Monitoring of chimerism and specific molecular markers as a surrogate measure of relapse is not always helpful; therefore, improved systems to detect early relapse are needed....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Aguirre-Ruiz, Paula, Ariceta, Beñat, Viguria, María Cruz, Zudaire, María Teresa, Blasco-Iturri, Zuriñe, Arnedo, Patricia, Aguilera-Diaz, Almudena, Jauregui, Axier, Mañú, Amagoia, Prosper, Felipe, Mateos, María Carmen, Fernández-Mercado, Marta, Larráyoz, María José, Redondo, Margarita, Calasanz, María José, Vázquez, Iria, Bandrés, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760908/
https://ncbi.nlm.nih.gov/pubmed/33255857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9123818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados